JF
CRVS icon

Jump Financial’s Corvus Pharmaceuticals CRVS Stock Holding History

Jump Financial’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.16M Buy
+147,850
New +$2.36M 0.03% 622
2025
Q2 		– Sell
-45,013
Closed -$143K – 1854
2025
Q1 		$143K Buy
+45,013
New +$212K ﹤0.01% 1475
2022
Q1 		– Sell
-55,500
Closed -$134K – 1605
2021
Q4 		$134K Buy
+55,500
New +$215K 0.01% 1183

Other funds holding CRVS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jump Financial's CRVS Position: Q1 2026 in Review

Jump Financial opened a new position in Corvus Pharmaceuticals (CRVS) in Q1 2026: 147,850 shares worth $2.16M. The stake represents 0.03% of the portfolio and ranks #622 among its holdings. This is a return to the name: Jump Financial previously reported a position in CRVS as recently as Q1 2025.

Jump Financial first reported a position in CRVS in Q4 2021 and has held it in 3 quarters since. 164 funds tracked by Wall St. Rank hold CRVS as of Q1 2026.

  • Jump Financial held 147,850 shares of Corvus Pharmaceuticals worth $2.16M as of Q1 2026.
  • Corvus Pharmaceuticals was a new Jump Financial position in Q1 2026.
  • Corvus Pharmaceuticals made up 0.03% of Jump Financial's portfolio in Q1 2026, its #622 holding.
  • Jump Financial first reported a position in Corvus Pharmaceuticals in Q4 2021 and has held it in 3 quarters since.
  • 164 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.